Clinical Trial Update: Vitamin D and Grass Pollen Specific Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vitamin D as an adjunct to grass pollen-specific immunotherapy for allergic rhinoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Grass pollen-specific immunotherapy extract (Grass pollen extract immunotherapy)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED